<DOC>
	<DOCNO>NCT00518934</DOCNO>
	<brief_summary>The purpose study analyze safety efficiency therapeutic angiogenesis patient limb ischemia transplantation human cord blood mononuclear cell .</brief_summary>
	<brief_title>Study Safety Efficiency Therapeutic Angiogenesis Patients With Limb Ischemia Transplantation Human Cord Blood Mononuclear Cell</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<criteria>Patients ischemic symptom claudication , rest pain nonhealing ischemic wound Without evidence improvement response conventional medical therapy Not candidate surgical intervention radiologic intervention Malignant disease More 60 year old Other significant medical condition , include diabetes mellitus , hypertension , hyperlipidemia , etc .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Safety efficiency angiogenesis patient limb</keyword>
	<keyword>ischemia transplantation human cord blood mononuclear</keyword>
	<keyword>cell</keyword>
</DOC>